학술논문

Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib.
Document Type
journal article
Source
Future Oncology; Sep2022, Vol. 18 Issue 27, p3021-3030, 10p
Subject
ALPHA fetoproteins
PYRIDINE
RESEARCH
LIVER tumors
UREA
RESEARCH methodology
PROGNOSIS
EVALUATION research
COMPARATIVE studies
HEPATOCELLULAR carcinoma
Language
ISSN
14796694
Abstract
Copyright of Future Oncology is the property of Future Medicine Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)